Related Experiment Video
Updated: Jul 5, 2026

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
Published on: February 13, 2013
Thrombin regulates CD40 expression in microglial cells
Jonathan R Weinstein1, Russell E Ettinger, Matthew Zhang
1Department of Neurology, School of Medicine, University of Washington, Seattle, Washington 98195, USA. jweinste@u.washington.edu
Abstract:
Microglial cells are the innate immune cells of the central nervous system and quickly respond to injury by proliferation, cytokine release, and increased cell surface antigen expression. Thrombin is a multifunctional serine proteinase, which has the capability to activate microglial cells. Here, we report that pharmaceutical-grade thrombin dose-dependently increases the expression of CD40 in N9 microglial cells. This effect is blocked by a thrombin inhibitor, mimicked by thrombin receptor-activating peptide and modified by mitogen-activated protein kinase pathway inhibitors. Thrombin-induced CD40 regulation might play a role in diseases with breakdown of the blood-brain barrier such as multiple sclerosis or stroke.
Insights
Thrombin activates microglial cells, increasing CD40 expression in a dose-dependent manner. This finding suggests a role for thrombin in central nervous system inflammatory diseases like stroke.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Biochemistry
Background:
- Microglial cells are key innate immune cells in the central nervous system.
- They rapidly respond to injury via proliferation, cytokine release, and antigen expression.
- Thrombin, a serine proteinase, can activate microglial cells.
Purpose of the Study:
- To investigate the effect of thrombin on microglial cell activation.
- To determine the role of thrombin in regulating CD40 expression on microglial cells.
Main Methods:
- Utilized N9 microglial cells for experiments.
- Administered pharmaceutical-grade thrombin and measured CD40 expression.
- Employed thrombin inhibitors, thrombin receptor-activating peptide, and MAPK pathway inhibitors.
Main Results:
- Thrombin dose-dependently increased CD40 expression in N9 microglial cells.
- Thrombin inhibition blocked this effect.
- Thrombin receptor-activating peptide mimicked the effect.
- Mitogen-activated protein kinase pathway inhibitors modified the response.
Conclusions:
- Thrombin significantly upregulates CD40 expression on microglial cells.
- This interaction is mediated through thrombin receptors and MAPK pathways.
- Thrombin-induced CD40 regulation may contribute to neuroinflammation in conditions like multiple sclerosis and stroke.
